Notably, cg04123776 emerged as the more clinically relevant site, exhibiting a stronger negative correlation with PHOX1 expression, the highest hypomethylation level in tumor tissues, and more significant prognostic value. The gene discussed is PRRX1; the disease is neoplasm.